Pluristem Therapeutics Inc.
PLXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PLX. That does not mean none is planned.
Get an email about PLX's next catalysts
Track Pluristem Therapeutics (PLX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
PLX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.02 | FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
WebsitePLX-PAD
Hip Fracture
PLX-PAD Low dose
Intermittent Claudication
150M PLX-PAD
Total Hip Arthroplasty
300M PLX-PAD
Total Hip Arthroplasty
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PLX-PAD | Phase 3 | Hip Fracture | - | - |
PLX-PAD Low dose | Phase 2 | Intermittent Claudication | - | - |
150M PLX-PAD | Phase 2 | Total Hip Arthroplasty | - | - |
300M PLX-PAD | Phase 2 | Total Hip Arthroplasty | - | - |
Frequently asked questions
What is in Pluristem Therapeutics Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Pluristem Therapeutics Inc.'s (PLX) pipeline across Phase 3, Phase 2. Its lead program is PLX-PAD (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Pluristem Therapeutics Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Pluristem Therapeutics Inc. (PLX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PLX biotech catalysts?→
Add PLX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pluristem Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.